Nivolumab (NIVO) + Chemotherapy (chemo) Vs Chemo As First-Line (1L) Treatment for Advanced Gastric Cancer/gastroesophageal Junction Cancer/esophageal Adenocarcinoma (GC/GEJC/EAC): 5-Year (y) Follow-Up Results from CheckMate 649.
Journal of Clinical Oncology（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined